Cuprimine is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Bausch Health Americas Inc.. The primary component is Penicillamine.
Product ID | 25010-705_0e7bbe71-f1e5-47a0-b04b-a26cc605c57d |
NDC | 25010-705 |
Product Type | Human Prescription Drug |
Proprietary Name | Cuprimine |
Generic Name | Penicillamine |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 1970-12-04 |
Marketing Category | NDA / NDA |
Application Number | NDA019853 |
Labeler Name | Bausch Health Americas Inc. |
Substance Name | PENICILLAMINE |
Active Ingredient Strength | 250 mg/1 |
Pharm Classes | Antirheumatic Agent [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1970-12-04 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA019853 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1970-12-04 |
Ingredient | Strength |
---|---|
PENICILLAMINE | 250 mg/1 |
SPL SET ID: | 80e736d3-2017-4d68-94b4-38255c3c59c6 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
25010-705 | Cuprimine | penicillamine |
0378-0709 | D-Penamine | Penicillamine |
0037-4401 | Depen | Penicillamine |
0254-2000 | penicillamine | penicillamine |
0591-4171 | Penicillamine | Penicillamine |
43598-634 | Penicillamine | Penicillamine |
43975-309 | Penicillamine | Penicillamine |
49884-146 | Penicillamine | penicillamine |
51991-974 | Penicillamine | Penicillamine |
60505-4696 | Penicillamine | Penicillamine |
62559-970 | Penicillamine | Penicillamine |
68475-201 | Penicillamine | Penicillamine |
68682-020 | penicillamine | penicillamine |
70010-907 | Penicillamine | Penicillamine |
70748-153 | Penicillamine | Penicillamine |
71205-916 | Penicillamine | Penicillamine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CUPRIMINE 72163255 0760911 Live/Registered |
Merck & Co., Inc. 1963-02-21 |